GlassScriptPhysician profile
Deborah K Winburn
NPI 1982602439
$1,120.98
in general payments reported to CMS, 2019-2025
22 companies · $61.33 in 2025
The $61.33 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $90.96 · 2021: $200 · 2022: $397 · 2023: $220 · 2024: $31.37 · 2025: $61.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $312.66 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $171.27 | 2022-2023 | Azstarys |
| Glaxosmithkline, LLC. | $167.29 | 2019-2022 | |
| Pfizer INC. | $63.11 | 2022-2025 | |
| Neos Therapeutics, LP | $47.85 | 2019-2024 | Adzenys Xr-Odt |
| Ironshore Pharmaceuticals INC. | $42.92 | 2019-2023 | Jornay Pm |
| Ultragenyx Pharmaceutical INC. | $34.81 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $32.48 | 2023 | Gardasil 9, Vaxneuvance |
| Astrazeneca Pharmaceuticals LP | $30.82 | 2022-2023 | Flumist Quadrivalent |
| Cranial Technologies, INC | $28.49 | 2020-2022 | |
| Abbvie INC. | $21.11 | 2022 | |
| Sobi, INC | $18.29 | 2019 | |
| Sanofi Pasteur INC. | $17.68 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.36 | 2022 | |
| Kaleo, INC. | $16.70 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $16.54 | 2025 | Relexxii |
| Genentech USA, INC. | $15.84 | 2020 | |
| Phadia US INC. | $14.73 | 2021 | |
| Jazz Pharmaceuticals INC. | $14.71 | 2019 | |
| Biomarin Pharmaceutical INC. | $13.41 | 2024 | Voxzogo 1.2mg |
| Adlon Therapeutics L.P. | $12.11 | 2019 | |
| Arbor Pharmaceuticals, INC. | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Winburn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.